Company Filing History:
2 out of 6,907 
2 out of 174 Years Active: 1993
Title: The Innovations of Masazumi Terashima
Introduction
Masazumi Terashima is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of human monoclonal antibodies. His work has implications for treating infectious diseases, showcasing his innovative spirit and dedication to scientific advancement.
Latest Patents
Masazumi Terashima holds 2 patents that focus on human monoclonal antibodies. His first patent describes a human monoclonal antibody that has both prophylactic and therapeutic effects against infections caused by Pseudomonas aeruginosa. This antibody targets an epitope located in the outer core moiety of the lipopolysaccharide (LPS) of the microorganism. The patent also includes a hybridoma that produces this antibody, along with processes for preparing both the antibody and the hybridoma. His second patent further explores a human monoclonal antibody with similar effects against infectious diseases caused by serotypes A and H of Pseudomonas aeruginosa. This antibody targets a common structure in the O-antigen of these serotypes, and it also includes a hybridoma and processes for its production.
Career Highlights
Throughout his career, Masazumi Terashima has worked with prominent companies in the chemical and pharmaceutical industries. He has been associated with Sumitomo Chemical Company, Limited and Sumitomo Pharmaceuticals Company Limited. His experience in these organizations has contributed to his expertise in developing innovative solutions in biotechnology.
Collaborations
Masazumi Terashima has collaborated with notable colleagues, including Hiroshi Ochi and Hiroshi Ohtsuka. These collaborations have likely enriched his research and development efforts, leading to significant advancements in his field.
Conclusion
Masazumi Terashima's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the treatment of infectious diseases, demonstrating the importance of innovation in healthcare.